GCGJ — what changed in the latest 10-Q
A section-by-section comparison of GCGJ's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-07 vs the prior 10-Q · 2026-05-11
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −5 | ~2 | 5 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 9 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-07
During the six months ended June 30, 2026 and 2025, the Company generated zero revenues, respectively. The operating expenses for the same periods were comprised of operating expenses of $20,826 and $12,516, respectively, resulting in net losses of $20,826 and $12,516 for the six months ended June 3…
As of June 30, 2026, the Company had 3,870,600 shares of common stock issued and outstanding.
As of June 30, 2026, we had cash and cash equivalents of $0. The Company expects to obtain financing to meet our basic operating requirements for the next twelve months.
For the six months ended June 30, 2026, net cash used in operating activities was $10,678, compared to net cash used in operating activities of $500 for the six months ended June 30, 2025. Such increase was primarily attributable to the ongoing amortization of OTCID annual fee, as well as payments r…
For the six months ended June 30, 2026 and 2025, net cash used in investing activities was $0 and $0, respectively.
Text removed vs the prior filing · source: 10-Q · 2026-05-11
As of March 31, 2026, the Company had 3,870,600 shares of common stock issued and outstanding.
As of March 31, 2026, we had cash and cash equivalents of $0. The Company expects to obtain financing to meet our basic operating requirements for the next twelve months.
For the three months ended March 31, 2026, net cash used in operating activities was $7,178, compared to net cash used in operating activities of $0 for the three months ended March 31, 2025. Such increase was primarily attributable to the ongoing amortization of OTCID annual fees, as well as paymen…
For the three months ended March 31, 2026 and 2025, net cash used in investing activities was $0 and $0, respectively.
For the three months ended March 31, 2026, net cash provided by financing activities was $7,178, compared to the net cash provided by financing activities of $0 for the three months ended March 31, 2025. Such increase was due to more funds advanced from the non-related party, for the Company's opera…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice